Literature DB >> 11349271

Risk for de novo hepatitis B from antibody to hepatitis B core antigen-positive donors in liver transplantation in Singapore.

K H Lee, C T Wai, S G Lim, K Manjit, H L Lee, M Da Costa, S H Quak, K C Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11349271     DOI： 10.1002/lt.500070514

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  4 in total

1.  Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.

Authors:  Watcharasak Chotiyaputta; Shawn J Pelletier; Robert J Fontana; Anna S F Lok
Journal:  Hepatol Int       Date:  2010-07-29       Impact factor: 6.047

Review 2.  Expanded criteria donors.

Authors:  Sandy Feng; Jennifer C Lai
Journal:  Clin Liver Dis       Date:  2014-08       Impact factor: 6.126

Review 3.  Liver transplantation for viral hepatitis in 2015.

Authors:  Alberto Ferrarese; Alberto Zanetto; Martina Gambato; Ilaria Bortoluzzi; Elena Nadal; Giacomo Germani; Marco Senzolo; Patrizia Burra; Francesco Paolo Russo
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 4.  Kidney Transplantation From Donors with Hepatitis B.

Authors:  Massimiliano Veroux; Vincenzo Ardita; Daniela Corona; Alessia Giaquinta; Burcin Ekser; Nunziata Sinagra; Domenico Zerbo; Marco Patanè; Cecilia Gozzo; Pierfrancesco Veroux
Journal:  Med Sci Monit       Date:  2016-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.